PACTR201508001237608Other未知
Two regimens of medroxyprogesterone acetate for treatment of endometrial hyperplasia without atypia : a randomized clinical trial
Faculty of Medicine0 个研究点目标入组 100 人开始时间: 2015年8月12日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- Other
- 发起方
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 40 Year(s) 至 70 Year(s)（—）
- 性别
- Female
入选标准
- •no prior diagnosis of endometrial carcinoma, an intact uterus, with histologically confirmed endometrial hyperplasia (EH) without atypia
排除标准
- •Women with associated pathology as uterine fibroid, cervical or vaginal pathology, bleeding tendency, chronic liver disease and any contraindications to progestin therapy were excluded from the study.
研究者
相似试验
已完成
不适用
Clinical trial of Medroxyprogestrone acetate and Tranexamic acid in women with menorrhagiamenorrhagia.Excessive and frequent menstruation with regular cycleIRCT138802131641N3Research Asisstant of Tarbiat Modares University76
尚未招募
不适用
Comparison Of Two Different Drugs For Hormone Replacement In Women With Premature Ovarian InsufficiencyCTRI/2020/07/026376Maulana Azad Medical College
招募中
不适用
Effect of medroxyprogesterone acetate in the prevention of premature LH surge in IVF cyclesIRCT20191205045621N2Shiraz University of Medical Sciences100
已完成
1 期
Effect of medroxyprogesterone acetate compared with Cetrotide to prevent premature LH sudden increase in IVF cyclesFemale Infertility.Female infertilityIRCT2017010813566N8Vice chancellor for Research,Tabriz University Of Medical Sciences100
进行中（未招募）
1 期
sefulness of medroxyprogesterone acetate in the follicular phase for ovarian donors which are undergoing controlled ovarian stimulation (COS)EUCTR2017-002341-30-ESINSTITUTO VALENCIANO DE INFERTILIDAD (IVI)318